JWJisheng Wang

Jisheng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jisheng Wang has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Chen

    Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People’s Republic of China

    1 shared publication
  • Jing Li

    Department of Neurology, Mianyang people’s Hospital, Mianyang, Sichuan, People’s Republic of China

    1 shared publication
  • Tingrui Zhao

    Department of Clinical Pharmacy, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Comprehensive analysis of factors to consider when using glucocorticoids for sCAP: A review

    by Tingrui Zhao, Jing Li, Jing Chen, Jisheng Wang

    Severe community-acquired pneumonia (sCAP) is a serious respiratory disease that often requires urgent and comprehensive treatment. The use of glucocorticoids for the treatment of sCAP has been a focus of discussion in the medical community because of their potential benefits and safety concerns. A literature review showed that the benefits of glucocorticoids in the treatment of sCAP may be related to factors such as oxygenation index, high CRP levels, shock, non-influenza, female gender, early application, and hydrocortisone. The application of glucocorticoids in the treatment of sCAP needs to be considered on an individual basis, weighing the potential benefits and risks, and monitoring and preventing possible side effects.